Tiprogrel

Tiprogrel · Tianjin Institute of Pharmaceutical Research Co., Ltd

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Tiprogrel, covering 2025-01-06 to 2025-03-07. Get the full timeline:

Most recent: Clinical Trial Update: Study of Tiprogrel in the Treatment of High-risk Patients with Acute Ischemic Cerebrovascular Events (THRIVE). [Phase 2]

See pricing